Cannabis, the gut and the microbiome: an emerging connection

The gut hosts a microbial community

The gastrointestinal tract hosts a complex community of bacteria and other microorganisms. The gut microbiome is involved in digestion, metabolism, immune signaling and the function of the intestinal barrier. Researchers are also studying communication between microbes and the body's endocannabinoid system (ECS). The relationship is intriguing but is not yet a validated clinical method for choosing cannabis products.

The intestinal barrier is selective

Intestinal epithelial cells and their tight junctions help nutrients cross while limiting unwanted entry of microorganisms and harmful substances. When barrier function is disturbed, bacterial components such as lipopolysaccharide (LPS) can become more exposed to immune cells and contribute to inflammatory signaling. This is one reason gut permeability and local immunity are active fields of research.

The gut has cannabinoid signaling

CB1 and CB2 receptors and related ECS components can be found in enteric neural, immune and epithelial contexts. They participate in regulation of intestinal movement, secretion, pain perception, barrier function and inflammation. Research does not establish that every externally administered cannabinoid will influence these processes beneficially.

The microbiota–endocannabinoidome axis works in two directions

The microbiome may be associated with changes in endocannabinoid levels, receptor expression and lipid mediators; the ECS can in turn influence the intestinal environment in which microbes live. Investigators sometimes call this the microbiota–endocannabinoidome axis. Most proposed causal pathways still require careful experimental and clinical testing.

The endocannabinoidome is larger than CB1 and CB2

Alongside anandamide and 2-AG are related lipid mediators, enzymes and possible targets such as TRPV1, PPARs and GPR55. This wider network is often called the endocannabinoidome, or eCBome. It provides a richer scientific framework than treating cannabinoid activity as a simple on/off switch.

Dietary fiber, bacterial metabolites and SCFAs

Gut bacteria can ferment dietary fibers into short-chain fatty acids, including butyrate, propionate and acetate. Butyrate supports intestinal epithelial metabolism and barrier function. Changes in diet and microbial composition may affect these metabolites and, indirectly, local immune signaling and the eCBome. The exact relationships vary across individuals and experimental models.

Does cannabis change the microbiome?

Some animal studies describe shifts in microbial populations or metabolites following cannabinoid exposure. But many other variables—including age, diet, antibiotics, other medication, exercise and disease—can change the microbiome. Current findings cannot justify claiming that cannabis reliably “repairs the microbiome” in patients.

CBD, inflammation and gut–brain communication

The Hebrew source discusses preclinical questions involving CBD, oxidative stress, NF-κB, Nrf2 and NLRP3, as well as the gut barrier. The gut and brain communicate through neural, hormonal, immune and microbial-metabolite pathways. Their association with anxiety or neurologic disease does not demonstrate that cannabis treats those conditions by altering gut bacteria.

Why Crohn’s disease and colitis are important examples

Inflammatory bowel disease can involve changed microbial ecology, barrier impairment, immune activation and altered ECS signaling. These overlapping observations motivate research. They do not establish that cannabis heals intestinal inflammation, even if some people report feeling less pain or nausea. Objective disease assessment remains essential.

Toward a more individualized research approach

A future study might examine gut microbial profiles, anandamide and 2-AG, inflammatory biomarkers, barrier measures, diet and clinical outcomes together. That is a research proposal, not an available validated patient-matching test. Lifestyle factors such as food, stress, sleep and activity may influence ECS-related biology even without cannabis use.

Key conclusions

The gut microbiome and endocannabinoid signaling appear connected through multiple biological routes. Research is still early, especially regarding human treatment outcomes. The responsible conclusion is not that cannabis is good for everyone's microbiome, but that better studies may identify which pathways matter, for whom and under which conditions.

Read original Hebrew article ↗

Scientific sources cited by the Hebrew original

1. Wang Y, et al. Symphony of the gut microbiota and endocannabinoidome: a molecular and functional perspective. 2025. Find this source ↗
2. Role of the Endocannabinoid System in the Regulation of Intestinal Homeostasis. Find this source ↗
3. The dual roles of natural cannabidiol in combating oxidative stress and inflammation: A potential intestinal guardian. 2026. Find this source ↗